Tools and strategies for the reduction of inappropriate implantable cardioverter defibrillator shocks

Europace

Volumn 10, Issue 11, 2008, Pages 1256-1265

  Tzeis, Stylianos ^a   Andrikopoulos, George ^b   Kolb, Christof ^a   Vardas, Panos E ^c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b EVANGELISMOS HOSPITAL   (Greece)

^c UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

ICD programming; Implantable cardioverter defibrillator; Inappropriate shock

Indexed keywords

ALGORITHM; ARRHYTHMOGENESIS; ARTIFICIAL HEART PACEMAKER; DEFIBRILLATOR; HEART DEATH; HIGH RISK PATIENT; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK REDUCTION; SHOCK;

ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT FAILURE; EQUIPMENT FAILURE ANALYSIS; HUMANS;

EID: 55249106435     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eun205     Document Type: Review

References (78)

1. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. New Engl J Med 1997;337:1576-83.
2. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS et al. Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-302.
3. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia: Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-40.
4. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
5. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
6. Kenigsberg DN, Ellenbogen KA. ICD arrhythmia detection and discrimination: are we there yet? J Cardiovasc Electrophysiol 2006;17:1320-2.
7. Glikson M, Lipchenca I, Viskin S, Ballman KV, Trusty JM, Gurevitz OT et al. Long-term outcome of patients who received implantable cardioverter defibrillators for stable ventricular tachycardia. J Cardiovasc Electrophysiol 2004;15:658-64.
8. Hreybe H, Ezzeddine R, Barrington W, Bazaz R, Jain S, Ngwu O et al. Relation of advanced heart failure symptoms to risk of inappropriate defibrillator shocks. Am J Cardiol 2006;97:544-6.
9. Germano JJ, Reynolds M, Essebag V, Josephson ME. Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic? Am J Cardiol 2006;97:1255-61.
10. Sweeney MO, Wathen MS, Volosin K, Abdalla I, DeGroot PJ, Otterness MF et al. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial. Circulation 2005;111:2898- 905.
11. Heller SS, Ormont MA, Lidagoster L, Sciacca RR, Steinberg S. Psychosocial outcome after ICD implantation: a current perspective. Pacing Clin Electrophysiol 1998;21:1207-15.
12. Lemon J, Edelman S, Kirkness A. Avoidance behaviors in patients with implantable cardioverter defibrillators. Heart Lung 2004;33:176- 82.
13. Kamphuis HC, de Leeuw JR, Derksen R, Hauer RN, Winnubst JA. Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study. Europace 2003;5:381-9.
14. Bilge AK, Ozben B, Demircan S, Cinar M, Yilmaz E, Adalet K. Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors. Pacing Clin Electrophysiol 2006;29:619-26.
15. Ladwig KH, Deisenhofer I, Simon H, Schmitt C, Baumert JJ. Characteristics associated with low treatment satisfaction in patients with implanted cardioverter defibrillators: results from the LICAD study. Pacing Clin Electrophysiol 2005;28:506-13.
16. Vollmann D, Luthje L, Vonhof S, Unterberg C. Inappropriate therapy and fatal proarrhythmia by an implantable cardioverter-defibrillator. Heart Rhythm 2005;2:307-9.
17. Healy E, Goyal S, Browning C, Robotis D, Ramaswamy K, Rofino-Nadoworny K et al. Inappropriate ICD therapy due to proarrhythmic ICD shocks and hyperpolarization. Pacing Clin Electrophysiol 2004;27:415-6.
18. Veltmann C, Borggrefe M, Schimpf R, Wolpert C. Fatal inappropriate ICD shock. J Cardiovasc Electrophysiol 2007;18:326-8.
19. Rosenqvist M, Beyer T, Block M, den Dulk K, Minten J, Lindemans F. Adverse events with transvenous implantable cardioverterdefibrillators: a prospective multicenter study. European 7219 Jewel ICD investigators. Circulation 1998;98:663-70.
20. Wilkoff BL, Hess M, Young J, Abraham WT. Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients. J Cardiovasc Electrophysiol 2004;15:1002-9.
21. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (Pain-FREE Rx II) trial results. Circulation 2004;110:2591-6.
22. Kolb C, Zrenner B, Schmitt C. Incidence of electromagnetic interference in implantable cardioverter defibrillators. Pacing Clin Electrophysiol 2001;24:465-8.
23. Brugada J, Mont L, Figueiredo M, Valentino M, Matas M, Navarro-López F. Enhanced detection criteria in implantable defibrillators. J Cardiovasc Electrophysiol 1998;9:261-8.
24. Swerdlow CD, Ahern T, Chen PS, Hwang C, Gang E, Mandel Wet al. Under-detection of ventricular tachycardia by algorithms to enhance specificity in a tiered-therapy cardioverter-defibrillator. J Am Coll Cardiol 1994;24:416-24.
25. Bänsch D, Steffgen F, Grönefeld G, Wolpert C, Böcker D, Mletzko RU et al. The 1+1 trial: a prospective trial of a dual- versus a single-chamber implantable defibrillator in patients with slow ventricular tachycardias. Circulation 2004;110:1022-9.
26. Schaumann A, von zur Mühlen F, Gonska BD, Kreuzer H. Enhanced detection criteria in implantable cardioverter-defibrillators to avoid inappropriate therapy. Am J Cardiol 1996;78:42-50.
27. Swerdlow CD, Chen PS, Kass RM, Allard JR, Peter CT. Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator. J Am Coll Cardiol 1994;23:1342-55.
28. Weber M, Böcker D, Bänsch D, Brunn J, Castrucci M, Gradaus R et al. Efficacy and safety of the initial use of stability and onset criteria in implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 1999;10:145-53.
29. Kettering K, Dörnberger V, Lang R, Vonthein R, Suchalla R, Bosch RF et al. Enhanced detection criteria in implantable cardioverter defibrillators: sensitivity and specificity of the stability algorithm at different heart rates. Pacing Clin Electrophysiol 2001;24:1325-33.
30. García-Alberola A, Yli-Mäyry S, Block M, Haverkamp W, Martínez-Rubio A, Kottkamp H et al. RR interval variability in irregular monomorphic ventricular tachycardia and atrial fibrillation. Circulation 1996;93:295-300.
31. Klein GJ, Gillberg JM, Tang A, Inbar S, Sharma A, Unterberg-Buchwald C et al. Improving SVT discrimination in single chamber ICDs - a new electrogram morphology based algorithm. J Cardiovasc Electrophysiol 2006;17:1310-9.
32. Boriani G, Occhetta E, Pistis G, Menozzi C, Jorfida M, Sermasi S et al. Combined use of morphology discrimination, sudden onset, and stability as discriminating algorithms in single chamber cardioverter defibrillators. Pacing Clin Electrophysiol 2002;25:1357-66.
33. Theuns DA, Rivero-Ayerza M, Goedhart DM, van der Perk R, Jordaens LJ. Evaluation of morphology discrimination for ventricular tachycardia diagnosis in implantable cardioverter-defibrillators. Heart Rhythm 2006;3:1332-8.
34. Grönefeld GC, Schulte B, Hohnloser SH, Trappe HJ, Korte T, Stellbrink C et al. Morphology discrimination: a beat-to-beat algorithm for the discrimination of ventricular from supraventricular tachycardia by implantable cardioverter defibrillators. Pacing Clin Electrophysiol 2001;24:1519-24.
35. Gold MR, Shorofsky SR, Thompson JA, Kim J, Schwartz M, Bocek J et al. Advanced rhythm discrimination for implantable cardioverter defibrillators using electrogram vector timing and correlation. J Cardiovasc Electrophysiol 2002;13:1092-7.
36. Corbisiero R, Lee MA, Nabert DR, Coman JA, Breiter DJ, Schwartz M et al. Performance of a new single-chamber ICD algorithm: discrimination of supraventricular and ventricular tachycardia based on vector timing and correlation. Europace 2006;8:1057-61.
37. Compton SJ, Merrill JJ, Dorian P, Cao J, Zhou D, Gillberg JM. Continuous template collection and updating for electrogram morphology discrimination in implantable cardioverter defibrillators. Pacing Clin Electrophysiol 2006;29:244-54.
38. Lüthje L, Vollmann D, Rosenfeld M, Unterberg-Buchwald C. Electrogram configuration and detection of supraventricular tachycardias by a morphology discrimination algorithm in single chamber ICDs. Pacing Clin Electrophysiol 2005;28:555-60.
39. Wolber T, Binggeli C, Holzmeister J, Brunckhorst C, Strobel U, Boes C et al. Wavelet-based tachycardia discrimination in ICDs: impact of posture and electrogram configuration. Pacing Clin Electrophysiol 2006;29:1255-60.
40. Aliot E, Nitzsché R, Ripart A. Arrhythmia detection by dual-chamber implantable cardioverter defibrillators. A review of current algorithms. Europace 2004;6:273-86.
41. Wilkoff BL, Kuhlkamp V, Volosin K, Ellenbogen K, Waldecker B, Kacet S et al. Critical analysis of dual chamber implantable cardioverterdefibrillator arrhythmia detection: Results and technical considerations. Circulation 2001;103:381-6.
42. Smart Detection algorithm functioning. Biotronik Lumax Function Manual.
43. Theuns D, Klootwijk AP, Kimman GP, Szili-Török T, Roelandt JR, Jordaens L. Initial clinical experience with a new arrhythmia detection algorithm in dual chamber implantable cardioverter defibrillators. Europace 2001;3:181-6.
44. Sinha AM, Stellbrink C, Schuchert A, Mox B, Jordaens L, Lamaison D et al. Clinical experience with a new detection algorithm for differentiation of supraventricular from ventricular tachycardia in a dual-chamber defibrillator. J Cardiovasc Electrophysiol 2004;15:646-52.
45. PARAD/PARAD+:. Cardiac Rhythm Management: Sorin group. http:// www.sorin-crm.com/sorin_elamedical/read/intl-medical-professionals- tachyarrhythmia-management-features-parad-parad-.
46. Anselme F, Mletzko R, Bowes R, Mabo P, Sadoul N, Schoels W et al. Prevention of inappropriate shocks in ICD recipients: a review of 10,000 tachycardia episodes. Pacing Clin Electrophysiol 2007;30:S128- S133.
47. The Boston Scientific Cardiac Rhythm Management Compass. 2007; Rhythm ID-DR Detection Enhancement Mode.
48. Lee MA, Corbisiero R, Nabert DR, Coman JA, Giudici MC, Tomassoni GF et al. Clinical results of an advanced SVT detection enhancement algorithm. Pacing Clin Electrophysiol 2005;28:1032-40.
49. Medtronic Virtuoso DR Manual. http://manuals.medtronic.com/Order Management.
50. Dijkman B, Wellens HJ. Dual chamber arrhythmia detection in the implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 2000;11:1105-15.
51. Kühlkamp V, Wilkoff BL, Brown AB, Volosin KJ, Hügl BJ, Stafford W et al. Experience with a dual chamber implantable defibrillator. Pacing Clin Electrophysiol 2002;25:1041-8.
52. Boriani G, Biffi M, Dall'Acqua A, Martignani C, Frabetti L, Zannoli R et al. Rhythm discrimination by rate branch and QRS morphology in dual chamber implantable cardioverter defibrillators. Pacing Clin Electrophysiol 2003;26:466-70.
53. Bailin SJ, Niebauer M, Tomassoni G, Leman R The Photon Investigators. Clinical investigation of a new dual-chamber implantable cardioverter defibrillator with improved rhythm discrimination capabilities. J Cardiovasc Electrophysiol 2003;14:144-9.
54. Hintringer F, Deibl M, Berger T, Pachinger O, Roithinger FX. Comparison of the specificity of implantable dual chamber defibrillator detection algorithms. Pacing Clin Electrophysiol 2004;27:976-82.
55. Berger RD, Lerew DR, Smith JM, Pulling C, Gold MR. The Rhythm ID Going Head to Head Trial (RIGHT): design of a randomized trial comparing competitive rhythm discrimination algorithms in implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 2006;17:749-53.
56. Gatzoulis KA, Gialafos IE. Dual chamber antitachycardia cardioverter defibrillators. Another step for the treatment of high-risk patients. Hellenic J Cardiol 2003;44:71-9.
57. Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H et al. European Society of Cardiology; European Heart Rhythm Association. Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Europace 2007;9:959-98.
58. Cleland JG, Coletta AP, Abdellah AT, Witte KK, Hobson N, Clark AL. Clinical trials update from Heart Rhythm 2007 and Heart Failure 2007: CARISMA, PREPARE, DAVID II, SAVE-PACE, PROTECT and AREA-IN-CHF. Eur J Heart Fail 2007;9:850-3.
59. Theuns DA, Rivero-Ayerza M, Boersma E, Jordaens L. Prevention of inappropriate therapy in implantable defibrillators: a meta-analysis of clinical trials comparing single-chamber and dual-chamber arrhythmia discrimination algorithms. Int J Cardiol 2008;125:352-7.
60. Deisenhofer I, Kolb C, Ndrepepa G, Schreieck J, Karch M, Schmieder S et al. Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study. J Cardiovasc Electrophysiol 2001;12:134-42.
61. Kuhlkamp V, Dornberger V, Mewis C, Suchalla R, Bosch RF, Seipel L. Clinical experience with the new detection algorithms for atrial fibrillation of a defibrillator with dual chamber sensing and pacing. J Cardiovasc Electrophysiol 1999;10:905-15.
62. Friedman PA, McClelland RL, Bamlet WR, Acosta H, Kessler D, Munger TM et al. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the Detect SupraVentricular Tachycardia study. Circulation 2006;113:2871-9.
63. Theuns DA, Klootwijk AP, Goedhart DM, Jordaens LJ. Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms. J Am Coll Cardiol 2004;44:2362-7.
64. Goldberger Z, Elbel B, McPherson CA, Paltiel AD, Lampert R. Cost advantage of dual-chamber versus single-chamber cardioverter-defibrillator implantation. J Am Coll Cardiol 2005;46:850-7.
65. Kolb C, Wille B, Maurer D, Schuchert A, Weber R, Schibgilla V et al. Management of far-field R wave sensing for the avoidance of inappropriate mode switch in dual chamber pacemakers: results of the FFS-test study. J Cardiovasc Electrophysiol 2006;17:992-7.
66. Wilkoff BL, Ousdigian KT, Sterns LD, Wang ZJ, Wilson RD, Morgan JM. A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial. J Am Coll Cardiol 2006;48:330-9.
67. Rauwolf T, Guenther M, Hass N, Schnabel A, Bock M, Braun MU et al. Ventricular oversensing in 518 patients with implanted cardiac defibrillators: incidence, complications, and solutions. Europace 2007;9:1041-7.
68. Occhetta E, Bortnik M, Magnani A, Francalacci G, Marino P. Inappropriate implantable cardioverter-defibrillator discharges unrelated to supraventricular tachyarrhythmias. Europace 2006;8:863-9.
69. Schimpf R, Wolpert C, Gaita F, Giustetto C, Borggrefe M. Short QT syndrome. Cardiovasc Res 2005;67:357-66.
70. Wathen MS, Sweeney M, DeGroot PJ, Stark AJ, Koehler JL, Chrisner MB et al. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation 2001;104:796-801.
71. Yee R, Klein G, Guiradon GM, Jones DL, Sharma Ad, Norris C. Initial clinical experience with the pacemaker cardioverter-defibrillator. Can J Cardiol 1990;6147-56.
72. Luceri R, Habal SM, David IB, Puchferran RL, Murtore C. Changing trends in therapy delivery with a third generation noncommitted implantable cardioverter defibrillator: results of a large single center clinical trial. Pacing Clin Electrophysiol 1993;16:159-64.
73. Wilkoff BL, Stern R, Williamson B, Wathen M, Holloman K, Fieberg A et al. Aggressively programmed implantable defibrillator detection and therapy reduces shocks compared to physician-tailored programming in primary prevention patients: results from the PREPARE trial. Heart Rhythm Society 2007 Scientific Sessions. Denver, CO, 10 May 2007.
74. Gunderson BD, Abeyratne AI, Olson WH, Swerdlow CD. Effect of programmed number of intervals to detect ventricular fibrillation on implantable cardioverter-defibrillator aborted and unnecessary shocks. Pacing Clin Electrophysiol 2007;30:157-65.
75. Arenal A, Ortiz M, Peinado R, Merino JL, Quesada A, Atienza F et al. Differentiation of ventricular and supraventricular tachycardias based on the analysis of the first postpacing interval after sequential antitachycardia pacing in implantable cardioverter-defibrillator patients. Heart Rhythm 2007;4:316-22.
76. Ridley DP, Gula LJ, Krahn AD, Skanes AC, Yee R, Brown ML et al. Atrial response to ventricular antitachycardia pacing discriminates mechanism of 1:1 atrioventricular tachycardia. J Cardiovasc Electrophysiol 2005;16:601-5.
77. Saba S, Baker L, Ganz L, Barrington W, Jain S, Ngwu O et al. Simultaneous atrial and ventricular anti-tachycardia pacing as a novel method of rhythm discrimination. J Cardiovasc Electrophysiol 2006;17:695- 701.
78. Schmidt B, Asbach S, Schweika O, Zehender M, Bode C, Faber TS. Atrial fibrillation reduces the atrial impedance amplitude during cardiac cycle: a novel detection algorithm to improve recognition of atrial fibrillation in pacemaker patients. Europace. 2007;9:812-6.